Call on ‘generics drugs only’ clause after internal talks, says govt

New Delhi : Union health minister Mansukh Mandaviya held a meeting on Monday to discuss contentious issues related to the newly notified regulations by the National Medical Council (NMC). The minister said he will take an ‘appropriate decision’ after internal discussions, people in the know told ET.

The Indian Medical Association (IMA) has vehemently opposed the National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2023, which mandate doctors to prescribe only generic drugs. The other contentious issue discussed during the meeting was medical conferences in five-star hotels with cocktail dinners. The NMC has barred doctors from participating in seminars, workshops, or conferences that “involve direct or indirect sponsorships from pharma companies or the allied health sector”.

“The meeting went very well. It lasted two hours as the minister gave the opportunity to everyone. We have presented what the medical fraternity feels. The government will take a decision later on the issues,” said Dr Sharad Agarwal, national president, IMA. The meeting was attended by IMA officials, drug lobby group Indian Pharmaceutical Alliance (IPA), officials from the ministry, and the NMC.

Related Posts

  • Pharma
  • June 17, 2025
  • 109 views
Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Bengaluru-based biopharmaceutical firm Biocon on Monday launched a qualified institutions placement (QIP) to raise Rs 4,500 crore. As part of the offering, the firm will issue up to 139 million…

  • Pharma
  • June 17, 2025
  • 107 views
Zydus Healthcare appoints Swati Dalal MD

Zydus Lifesciences Ltd on Monday announced the appointment of Swati Dalal as an additional director and Managing Director of its wholly-owned arm Zydus Healthcare Ltd. The board of Zydus Healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco API plant gets one observation from FDA

Natco API plant gets one observation from FDA